9.89

2.59% 0.25

Pre-market: 9.58 -0.31 -3.13%

Enfusion Inc (ENFN)

Overview News Price History Option Chain Discussions Forecast

Enfusion Inc stock is traded at $9.89, with a volume of 396.32K. It is up +2.59% in the last 24 hours and up +12.90% over the past month. Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Previous Close:

$9.64

Open:

$9.6

24h Volume:

396.32K

Relative Volume:

1.04

Market Cap:

$933.34M

Revenue:

$174.54M

Net Income/Loss:

$6.03M

P/E Ratio:

123.62

EPS:

0.08

Net Cash Flow:

$15.96M

1W Performance:

+2.06%

1M Performance:

+12.90%

6M Performance:

+5.44%

1Y Performance:

+0.82%

1-Day Range:

$9.60

$9.985

1-Week Range:

$9.51

$10.12

52-Week Range:

$7.52

$10.45

Enfusion Inc Stock (ENFN) Company Profile

Name

Enfusion Inc

Sector

Technology (782)

Industry

Software - Application (242)

Phone

(312) 253-9800

Address

125 SOUTH CLARK STREET, SUITE 750, CHICAGO

Employee

1,102

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

ENFN's Discussions on Twitter

Compare ENFN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENFN	9.89	933.34M	174.54M	6.03M	15.96M	0.08
CRM	325.70	309.29B	36.47B	5.63B	11.46B	1.59
SAP	235.02	271.00B	36.09B	2.98B	7.67B	5.2918
NOW	1,022.98	209.86B	10.46B	1.34B	3.35B	7.72
INTU	650.60	180.93B	16.29B	2.96B	4.63B	8.44
UBER	69.60	146.00B	41.96B	4.40B	5.96B	-0.22

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Initiated	Piper Sandler	Neutral
Mar-15-23	Initiated	JP Morgan	Neutral
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-03-22	Downgrade	BofA Securities	Buy → Neutral
Nov-15-21	Initiated	BofA Securities	Buy
Nov-15-21	Initiated	Credit Suisse	Neutral
Nov-15-21	Initiated	Goldman	Neutral
Nov-15-21	Initiated	Morgan Stanley	Equal-Weight
Nov-15-21	Initiated	Piper Sandler	Overweight
Nov-15-21	Initiated	Stifel	Buy
Nov-15-21	Initiated	William Blair	Outperform

View All

Enfusion Inc Stock (ENFN) Latest News

Nov 20, 2024

Enfusion Executives to Present at Wells Fargo TMT Summit & UBS AI Conference | ENFN Stock News - StockTitan

Nov 20, 2024

Nov 16, 2024

Impax Asset Management Group plc Acquires 136,948 Shares of Enfusion, Inc. (NYSE:ENFN) - MarketBeat

Nov 16, 2024

Nov 15, 2024

52,800 Shares in Enfusion, Inc. (NYSE:ENFN) Bought by Versor Investments LP - MarketBeat

Nov 15, 2024

Short Interest in Enfusion, Inc. (NYSE:ENFN) Declines By 22.4% - MarketBeat

Nov 15, 2024

Nov 14, 2024

Loop landlords 601W, CommerzReal score rare office lease expansions - The Real Deal

Nov 14, 2024

Nov 12, 2024

There May Be Some Bright Spots In Enfusion's (NYSE:ENFN) Earnings - Yahoo Finance

Nov 12, 2024

Impax Asset Management Group plc Increases Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat

Nov 06, 2024

New York State Common Retirement Fund Sells 107,008 Shares of Enfusion, Inc. (NYSE:ENFN) - MarketBeat

Nov 06, 2024

Nov 05, 2024

Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Call Transcript - MSN

Nov 05, 2024

Nov 04, 2024

Enfusion, Inc. Reports Strong Q3 2024 Results - TipRanks

Nov 04, 2024

Earnings call: Enfusion reports robust Q3 growth with strong client gains - Investing.com Canada

Nov 04, 2024